Published in Int J Exp Pathol on August 01, 2012
Plasma levels of cathepsins L, K, and V and risks of abdominal aortic aneurysms: a randomized population-based study. Atherosclerosis (2013) 0.86
Selective cathepsin S inhibition attenuates atherosclerosis in apolipoprotein E-deficient mice with chronic renal disease. Am J Pathol (2015) 0.82
Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse. Arterioscler Thromb Vasc Biol (2014) 0.80
Adventitial Tertiary Lymphoid Organs as Potential Source of MicroRNA Biomarkers for Abdominal Aortic Aneurysm. Int J Mol Sci (2015) 0.78
Endothelial cells and cathepsins: Biochemical and biomechanical regulation. Biochimie (2015) 0.78
Cathepsins: a new culprit behind abdominal aortic aneurysm. Regen Med Res (2013) 0.75
Mechanisms of angiogenesis and arteriogenesis. Nat Med (2000) 13.88
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest (1994) 7.25
Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest (1998) 3.17
Emerging roles for cysteine proteases in human biology. Annu Rev Physiol (1997) 3.05
Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol (2006) 3.01
Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci U S A (1995) 2.84
How does extracellular matrix control capillary morphogenesis? Cell (1989) 2.84
Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 2.28
Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest (1999) 2.03
Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol (2006) 2.00
Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol (1997) 1.99
Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation (1999) 1.97
World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res (1997) 1.80
Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med (2000) 1.70
Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis (2005) 1.59
Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ Res (2003) 1.51
Cathepsin-regulated apoptosis. Apoptosis (2006) 1.47
Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases. Am J Pathol (2007) 1.43
Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation. Exp Cell Res (2009) 1.35
Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans. Cardiovasc Res (2010) 1.33
An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg (2005) 1.23
Treatment of ruptured abdominal aortic aneurysm, a permanent challenge or a waste of resources? Prediction of outcome using a multi-organ-dysfunction score. Eur J Vasc Endovasc Surg (2000) 1.10
Cysteine cathepsins in the immune response. Tissue Antigens (2006) 1.07
Do cathepsins play a role in abdominal aortic aneurysm pathogenesis? Ann N Y Acad Sci (2006) 1.03
Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg (1996) 1.01
Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma. Neoplasma (2004) 1.00
Cysteine protease activity in the wall of abdominal aortic aneurysms. J Vasc Surg (2007) 0.97
Inflammatory infiltrates and neovessels are relevant sources of MMPs in abdominal aortic aneurysm wall. Pathobiology (2009) 0.97
Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3. Am J Pathol (2006) 0.93
Controlling the expansion of abdominal aortic aneurysms. Br J Surg (2003) 0.92
Meta-analysis of postoperative mortality after elective repair of abdominal aortic aneurysms detected by screening. Br J Surg (2011) 0.87
Distribution, activity and concentration of cathepsin B and cystatin C in the wall of aortic aneurysm. Pol J Pathol (1999) 0.77
Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science (2003) 4.40
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med (2012) 3.63
Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study. Lancet Neurol (2008) 2.53
Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology (2005) 2.25
Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg (2008) 2.24
Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med (2006) 1.98
Microembolic signals detected by transcranial Doppler sonography during carotid endarterectomy and correlation with serial diffusion-weighted imaging. Stroke (2004) 1.80
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood (2010) 1.76
Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology (2003) 1.72
Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation (2012) 1.71
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol (2004) 1.70
Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo. Cancer Cell (2013) 1.68
The impact of model assumptions on results of computational mechanics in abdominal aortic aneurysm. J Vasc Surg (2010) 1.61
Comparison between breast volume measurement using 3D surface imaging and classical techniques. Breast (2006) 1.51
C/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development (2005) 1.45
In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol (2004) 1.44
Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy. Eur J Nucl Med Mol Imaging (2004) 1.43
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells. Mol Cancer Ther (2006) 1.41
Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med (2009) 1.41
Therapeutic implications for the induced levels of Chk1 in Myc-expressing cancer cells. Clin Cancer Res (2011) 1.41
Fractalkine promotes platelet activation and vascular dysfunction in congestive heart failure. Thromb Haemost (2013) 1.41
Long-term results of balloon-expandable LifePath endografts in abdominal aortic aneurysm: a single-center experience. J Vasc Surg (2009) 1.40
Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. Mol Ther (2005) 1.33
Combined reporter gene PET and iron oxide MRI for monitoring survival and localization of transplanted cells in the rat heart. J Nucl Med (2009) 1.28
Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation (2005) 1.25
Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J (2005) 1.18
Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J (2003) 1.16
Differences in complication rates among the centres in the SPACE study. Neuroradiology (2008) 1.13
Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker. Am J Surg Pathol (2008) 1.12
Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty. FASEB J (2004) 1.10
Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck. Oncotarget (2011) 1.10
MDM2 antagonist nutlin-3 displays antiproliferative and proapoptotic activity in mantle cell lymphoma. Clin Cancer Res (2009) 1.07
Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133. Radiology (2010) 1.04
NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma. Blood (2006) 1.03
Association between carotid diameter and the advanced glycation end product N-epsilon-carboxymethyllysine (CML). Cardiovasc Diabetol (2009) 1.02
How should patients behave to facilitate shared decision making--the doctors' view. Health Expect (2011) 1.02
New aspects of breast volume measurement using 3-dimensional surface imaging. Ann Plast Surg (2006) 1.01
Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment. J Nucl Med (2011) 1.01
The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas. Oncotarget (2011) 1.00
C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway. Haematologica (2009) 0.98
Inflammatory infiltrates and neovessels are relevant sources of MMPs in abdominal aortic aneurysm wall. Pathobiology (2009) 0.97
Idiopathic aneurysm of the common iliac artery in an 11-year-old child. J Vasc Surg (2009) 0.96
Induction of apoptosis in murine neuroblastoma by systemic delivery of transferrin-shielded siRNA polyplexes for downregulation of Ran. Oligonucleotides (2008) 0.96
Retracted Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1. Circ Res (2008) 0.95
MRI plaque imaging reveals high-risk carotid plaques especially in diabetic patients irrespective of the degree of stenosis. BMC Med Imaging (2010) 0.95
Different capacity of monocyte subsets to phagocytose iron-oxide nanoparticles. PLoS One (2011) 0.94
Comparison of cyclic RGD peptides for αvβ3 integrin detection in a rat model of myocardial infarction. EJNMMI Res (2013) 0.94
Neovascularization and angiogenic factors in advanced human carotid artery stenosis. Circ J (2012) 0.94
Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1. PLoS One (2012) 0.93
Imaging of acute and chronic aortic dissection by 18F-FDG PET/CT. J Nucl Med (2010) 0.93
Molecular imaging of early αvβ3 integrin expression predicts long-term left-ventricle remodeling after myocardial infarction in rats. J Nucl Med (2012) 0.92
Optimization of 3-dimensional imaging of the breast region with 3-dimensional laser scanners. Ann Plast Surg (2006) 0.92
Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability. Int J Cardiovasc Imaging (2010) 0.91
Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX. Acad Radiol (2005) 0.91
Reporter gene PET for monitoring survival of transplanted endothelial progenitor cells in the rat heart after pretreatment with VEGF and atorvastatin. J Nucl Med (2009) 0.91
Indocyanine green-enhanced imaging of antigen-induced arthritis with an integrated optical imaging/radiography system. Arthritis Rheum (2010) 0.91
Quantitative assessment of glucose metabolism in the vessel wall of abdominal aortic aneurysms: correlation with histology and role of partial volume correction. Int J Cardiovasc Imaging (2012) 0.91
Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors. Nucl Med Biol (2008) 0.90
Multiple biological predictors for vulnerable carotid lesions. Cerebrovasc Dis (2009) 0.89
Re: factors determining shape and symmetry in immediate breast reconstruction. Ann Plast Surg (2004) 0.88
Pathophysiological mechanisms of carotid plaque vulnerability: impact on ischemic stroke. Arch Immunol Ther Exp (Warsz) (2012) 0.87
Littoral cell angioma and angiosarcoma of the spleen: report of two cases in siblings and review of the literature. J Gastrointest Surg (2011) 0.86
GP130 activation induces myeloma and collaborates with MYC. J Clin Invest (2014) 0.86
Synthesis and characterization of chemically condensed oligoethylenimine containing beta-aminopropionamide linkages for siRNA delivery. Biomaterials (2007) 0.85
Three-dimensional evaluation of breast augmentation and the influence of anatomic and round implants on operative breast shape changes. Aesthetic Plast Surg (2012) 0.84
Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. Eur J Nucl Med Mol Imaging (2015) 0.84
Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging. Magn Reson Med (2010) 0.84
Why calls for more routine carotid stenting are currently inappropriate: an international, multispecialty, expert review and position statement. Stroke (2013) 0.84
Nanoparticles bearing polyethyleneglycol-coupled transferrin as gene carriers: preparation and in vitro evaluation. Int J Pharm (2003) 0.84
Extracellular matrix metalloproteinase inducer (CD147) and membrane type 1-matrix metalloproteinase are expressed on tissue macrophages in calcific aortic stenosis and induce transmigration in an artificial valve model. J Thorac Cardiovasc Surg (2010) 0.83
Impact of chronic kidney disease on carotid plaque vulnerability. J Vasc Surg (2011) 0.83
CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice. Thromb Haemost (2013) 0.83
A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphoma. J Nucl Med (2011) 0.83
C-type natriuretic peptide inhibits constrictive remodeling without compromising re-endothelialization in balloon-dilated renal arteries. J Endovasc Ther (2005) 0.83
High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells. Int J Cancer (2012) 0.83
MRI plaque imaging detects carotid plaques with a high risk for future cerebrovascular events in asymptomatic patients. PLoS One (2013) 0.82
Evaluation of serum matrix metalloproteinases as biomarkers for detection of neurological symptoms in carotid artery disease. Vasc Endovascular Surg (2009) 0.82
Glucose metabolism in the vessel wall correlates with mechanical instability and inflammatory changes in a patient with a growing aneurysm of the abdominal aorta. Circ Cardiovasc Imaging (2009) 0.82
Paclitaxel delivered to adventitia attenuates neointima formation without compromising re-endothelialization after angioplasty in a porcine restenosis model. J Endovasc Ther (2006) 0.82
Stabilized nonviral formulations for the delivery of MCP-1 gene into cells of the vasculoendothelial system. Pharm Res (2004) 0.82
Endothelial differentiation of adipose-derived mesenchymal stem cells is improved by epigenetic modifying drug BIX-01294. Eur J Cell Biol (2012) 0.81
American Society of Anesthesiology and Rankin as predictive parameters for the outcome of carotid endarterectomy within 28 days after an ischemic stroke. J Stroke Cerebrovasc Dis (2007) 0.81